DUPONT DE NEMOURS Reports 6.9% Decrease in Total Revenue for Q2 2023
August 7, 2023
🌥️Earnings Overview
For the second quarter of fiscal year 2023 ending June 30, 2023, DUPONT DE NEMOURS ($NYSE:DD) reported total revenue of USD 3094.0 million, a 6.9% decrease from the same period last year. Net income for the quarter was USD -131.0 million, significantly lower than the 787.0 million that was reported in the prior year.
Analysis
According to the Star Chart, DUPONT DE NEMOURS is strong in dividend, medium in asset, profitability and weak in growth. This indicates that DUPONT DE NEMOURS is classified as a ‘cow’, a type of company with a track record of paying out consistent and sustainable dividends. Investors interested in such companies are typically income oriented investors who prioritize regular dividend payments above all else. In terms of DUPONT DE NEMOURS’s health score, it has an intermediate health score of 6/10 based on its cashflows and debt. This suggests that DUPONT DE NEMOURS has the potential to generate enough funds to pay off debt and invest in its future operations. Therefore, those investors who are interested in consistent dividend payments and long-term investing might find DUPONT DE NEMOURS an attractive option. More…
About the Company
Income Snapshot
Below shows the total revenue, net income and net margin for DD. More…
| Total Revenues | Net Income | Net Margin |
| 12.53k | 4.72k | 9.1% |
Cash Flow Snapshot
Below shows the cash from operations, investing and financing for DD. More…
| Operations | Investing | Financing |
| 597 | 9.95k | -7.37k |
Balance Sheet Snapshot
Below shows the total assets, liabilities and book value per share for DD. More…
| Total Assets | Total Liabilities | Book Value Per Share |
| 40.8k | 14.24k | 56.91 |
Key Ratios Snapshot
Some of the financial key ratios for DD are shown below. More…
| 3Y Rev Growth | 3Y Operating Profit Growth | Operating Margin |
| -15.4% | -4.2% | 14.7% |
| FCF Margin | ROE | ROA |
| -0.9% | 4.4% | 2.8% |
Peers
The competition between DuPont de Nemours Inc and its competitors is fierce. Alkyl Amines Chemicals Ltd, AMS Polymers Ltd, and Clean Science and Technology Ltd are all vying for market share in the highly competitive market for chemicals and polymers. DuPont de Nemours Inc has a long history of innovation and is a market leader in both fields. However, its competitors are not far behind, and are constantly innovating to try to gain an edge in the market.
– Alkyl Amines Chemicals Ltd ($BSE:506767)
Alkyl Amines Chemicals Ltd is an Indian company that produces and sells chemicals. It has a market cap of 147.64B as of 2022 and a Return on Equity of 19.42%. The company produces a variety of chemicals, including amines, alkyl halides, and alcohols. It also produces and sells a variety of other products, including detergents, cleaners, and solvents.
– AMS Polymers Ltd ($BSE:540066)
Sagar Dye-Chem Ltd has a market cap of 81.08M as of 2022, a Return on Equity of 8.31%. The company is engaged in the manufacturing of dyestuffs and pigments, textile auxiliaries, and process chemicals. It also provides services for the textile industry.
– Clean Science and Technology Ltd ($BSE:543318)
Science and Technology Ltd has a market cap of 170.17B as of 2022, a Return on Equity of 25.83%. The company is engaged in the business of scientific research and development and manufacture of scientific instruments, equipment and other products. It is one of the leading companies in this field in China.
Summary
Dupont De Nemours’ financial performance for the second quarter of fiscal year 2023 was largely impacted by the ongoing global health crisis. Revenue reported for the period ended June 30, 2023 decreased by 6.9% year-over-year to USD3094.0 million. Net income for the period reported a sharp decline of USD -131.0 million, compared to the USD787.0 million reported for the same period last year. Investors should be cautious when considering Dupont De Nemours as an investment option due to the unpredictable nature of the global economy and the company’s declining financials.
Related Posts
Recent Posts
